Does CMR identify myocardial extracellular expansion and replacement fibrosis to detect ventricular decompensation in patients with aortic stenosis?
CMR detection of myocardial fibrosis holds promise for tracking myocardial health and optimizing the timing of valve replacement in aortic stenosis.
CMR detects ventricular decompensation in aortic stenosis through the identification of myocardial extracellular expansion and replacement fibrosis. This holds major promise in tracking myocardial health in valve disease and for optimizing the timing of valve replacement. (The Role of Myocardial Fibrosis in Patients With Aortic Stenosis; NCT01755936).
Chin et al. (Wed,) studied this question.